As of May 24, 2025, Myovant Sciences Ltd (MYOV) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Myovant Sciences Ltd's Forward P/E to Peers
To better understand Myovant Sciences Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Myovant Sciences Ltd (MYOV) | - |
| Abcam PLC (ABC.L) | 4083.72 |
| Genus PLC (GNS.L) | 2684.49 |
| Krystal Biotech Inc (KRYS) | 20.20 |
Compared to its competitors, Myovant Sciences Ltd's Forward P/E is difficult to compare due to insufficient data.